Velocity Clinical Research is currently recruiting participants for a phase 3 clinical trial of retatrutide
Meet our doctors Last reviewed: 02 Jun 2026 Sources Saxenda 6 mg/mL solution for injection in pre-filled pen, EMC [accessed 26 January 2026] Wegovy 1 mg, FlexTouch solution for injection in pre-filled pen, EMC [accessed 26 January 2026] Accessing Wegovy for weight loss: Everything you need to know, Gov
IncreatinGLP-1, GLP-2, GIPGLP-1 " GLP-1 ,-14.9%,7-10 .
GLP-1 specifically inhibits glucagon secretion, which is especially advantageous for individuals with type-2 diabetes (T2DM) who often have increased glucagon levels
Nauck M, et al
With a reduction of 21 % in calorie intake (KPMG), a product must provide more protein and micronutrients per reduced portion nutritional density becomes the key design criterion, not a secondary consideration